Literature DB >> 25225598

MicroRNA regulation network in colorectal cancer metastasis.

Jiao-Jiao Zhou1, Shu Zheng1, Li-Feng Sun1, Lei Zheng1.   

Abstract

Colorectal cancer is the third most common cancer worldwide. Metastasis is a major cause of colorectal cancer-related death. Mechanisms of metastasis remain largely obscure. MicroRNA is one of the most important epigenetic regulators by targeting mRNAs post-transcriptionally. Accumulated evidence has supported its significant role in the metastasis of colorectal cancer, including epithelial-mesenchymal transition and angiogenesis. Dissecting microRNAome potentially identifies specific microRNAs as biomarkers of colorectal cancer metastasis. Better understanding of the complex network of microRNAs in colorectal cancer metastasis provide new insights in the biological process of metastasis and in the potential targets for colorectal cancer therapies and for diagnosis of recurrent and metastatic colorectal cancer.

Entities:  

Keywords:  Colorectal neoplasms; MicroRNAs; Neoplasm metastasis

Year:  2014        PMID: 25225598      PMCID: PMC4160524          DOI: 10.4331/wjbc.v5.i3.301

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  55 in total

1.  MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells.

Authors:  Yingjie Yu; Shailender S Kanwar; Bhaumik B Patel; Phil-Sun Oh; Jyoti Nautiyal; Fazlul H Sarkar; Adhip P N Majumdar
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.

Authors:  Mian Ling Chen; Liu Sen Liang; Xiao Kang Wang
Journal:  Clin Exp Metastasis       Date:  2012-03-10       Impact factor: 5.150

3.  A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.

Authors:  Ziad Kanaan; Henry Roberts; M Robert Eichenberger; Adrian Billeter; Gairy Ocheretner; Jianmin Pan; Shesh N Rai; Jeffery Jorden; Anna Williford; Susan Galandiuk
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

4.  The colorectal microRNAome.

Authors:  Jordan M Cummins; Yiping He; Rebecca J Leary; Ray Pagliarini; Luis A Diaz; Tobias Sjoblom; Omer Barad; Zvi Bentwich; Anna E Szafranska; Emmanuel Labourier; Christopher K Raymond; Brian S Roberts; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

5.  Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.

Authors:  Xing-xiang Pu; Guo-liang Huang; Hong-qiang Guo; Cheng-cheng Guo; Haoran Li; Shen Ye; Suxia Ling; Li Jiang; Ying Tian; Tong-yu Lin
Journal:  J Gastroenterol Hepatol       Date:  2010-10       Impact factor: 4.029

6.  MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype.

Authors:  Martha L Slattery; Erica Wolff; Michael D Hoffman; Daniel F Pellatt; Brett Milash; Roger K Wolff
Journal:  Genes Chromosomes Cancer       Date:  2010-12-16       Impact factor: 5.006

Review 7.  Epigenetics of colorectal cancer.

Authors:  Ajay Goel; C Richard Boland
Journal:  Gastroenterology       Date:  2012-09-20       Impact factor: 22.682

8.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

9.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.

Authors:  Sara Weis; Jianhua Cui; Leo Barnes; David Cheresh
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

10.  MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance.

Authors:  Chang Gong Lee; Susan McCarthy; Mike Gruidl; Cindy Timme; Timothy J Yeatman
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

View more
  11 in total

1.  miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor.

Authors:  Hong-Bo Zhang; Li-Chao Sun; Lan Ling; Lu-Hong Cong; Rui Lian
Journal:  Exp Ther Med       Date:  2016-07-27       Impact factor: 2.447

2.  MicroRNA-30a Inhibits Colorectal Cancer Metastasis Through Down-Regulation of Type I Insulin-Like Growth Factor Receptor.

Authors:  Y C Liu; Y R Park; S L Kim; S T Lee; S W Kim
Journal:  Dig Dis Sci       Date:  2017-09-20       Impact factor: 3.199

3.  miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma.

Authors:  Wei Lu; Yijian Zhang; Linzhu Zhou; Xuan Wang; Jiasheng Mu; Lin Jiang; Yunping Hu; Ping Dong; Yingbin Liu
Journal:  Tumour Biol       Date:  2015-11-06

4.  MicroRNA-613 targets FMNL2 and suppresses progression of colorectal cancer.

Authors:  Bai Li; Zhongshi Xie; Zhihong Li; Si Chen; Bo Li
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

5.  MicroRNA‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1.

Authors:  Guohui Nie; Hongfang Duan; Xiaoqing Li; Zhendong Yu; Liang Luo; Ruijing Lu; Ziliang Ji; Wei Zhang
Journal:  Mol Med Rep       Date:  2015-08-05       Impact factor: 2.952

6.  Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy.

Authors:  Bin Wei; Qiaoying Huang; Xiaogang Zhong
Journal:  Onco Targets Ther       Date:  2015-07-21       Impact factor: 4.147

7.  miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2.

Authors:  L Sheng; P He; X Yang; M Zhou; Q Feng
Journal:  Cell Death Dis       Date:  2015-07-09       Impact factor: 8.469

8.  Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer.

Authors:  Yajuan Li; Mattia Lauriola; Donghwa Kim; Mirko Francesconi; Gabriele D'Uva; Dave Shibata; Mokenge P Malafa; Timothy J Yeatman; Domenico Coppola; Rossella Solmi; Jin Q Cheng
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

9.  miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.

Authors:  Wei Lu; Yunping Hu; Qiang Ma; Linzhu Zhou; Lin Jiang; Zhizhen Li; Shuai Zhao; Yuzhen Xu; Weibin Shi; Sheng Li; Yingbin Liu
Journal:  Oncotarget       Date:  2016-09-20

10.  MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1.

Authors:  Jun Zhao; Jingjie Cao; Lurong Zhou; Yunyi Du; Xiaoling Zhang; Bo Yang; Yangjun Gao; Yu Wang; Ning Ma; Wei Yang
Journal:  Oncol Lett       Date:  2018-08-14       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.